Ann Clin Neurophysiol.  2017 Jan;19(1):50-53. 10.14253/acn.2017.19.1.50.

Acute-onset chronic inflammatory demyelinating polyneuropathy following hepatitis A virus infection

• Jung ES
• Kim YS
• Min JH
• Kang K
• Lee JJ
• Park JM
• Kim BK
• Kwon O

• KMID: 2367995
• DOI: http://doi.org/10.14253/acn.2017.19.1.50

Abstract

An infection is less likely to elicit chronic inflammatory demyelinating polyneuropathy (CIDP) than Guillain-Barré syndrome. We here report a case of acute-onset CIDP following hepatitis A virus infection and briefly comment on the potential mechanisms regarding the induction and chronicity of autoimmunity after a viral infection.

Keyword

Polyradiculoneuropathy, Chronic inflammatory demyelinating; Guillain-Barre syndrome; Hepatitis A virus

MeSH Terms

Autoimmunity
Guillain-Barre Syndrome
Hepatitis A virus*
Hepatitis A*
Hepatitis*
Polyneuropathies*
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Reference

1.Israeli E., Agmon-Levin N., Blank M., Chapman J., Shoenfeld Y. Guillain-Barre syndrome--a classical autoimmune disease trig-gered by infection or vaccination. Clin Rev Allergy Immunol. 2012. 42:121–130.

2.Meléndez-Vásquez C., Redford J., Choudhary PP., Gray IA., Maitland P., Gregson NA, et al. Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J Neuro-immunol. 1997. 73:124–134.

3.Horwitz MS., Sarvetnick N. Viruses, host responses, and autoimmunity. Immunol Rev. 1999. 169:241–253.

4.Manz RA., Moser K., Burmester GR., Radbruch A., Hiepe F. Immunological memory stabilizing autoreactivity. Curr Top Microbiol Immunol. 2006. 305:241–257.

5.Van den Bergh PY., Hadden RD., Bouche P., Cornblath DR., Hahn A., Illa I, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol. 2010. 17:356–363.

6.Ruts L., Drenthen J., Jacobs BC., van Doorn PA. Dutch GBS Study Group. Distinguishing acute-onset CIDP from fluctuat-ing Guillain-Barre syndrome: a prospective study. Neurology. 2010. 74:1680–1686.

7.Odaka M., Yuki N., Hirata K. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barre syndrome. J Neurol. 2003. 250:913–916.

8.Xie JG., Cai Y., Davis LE. Guillain-Barré syndrome and hepatitis A: lack of association during a major epidemic. Ann Neurol. 1988. 24:697–698.

9.Comi C., Osio M., Ferretti M., Mesturini R., Cappellano G., Chiocchet-ti A, et al. Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP. J Peripher Nerv Syst. 2009. 14:101–106.

10.Tackenberg B., Jelcic I., Baerenwaldt A., Oertel WH., Sommer N., Nimmerjahn F, et al. Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy. Proc Natl Acad Sci U S A. 2009. 106:4788–4792.